Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

被引：45
|
作者：
Prebet, Thomas [1 ,2 ,3 ]
Gore, Steven D. [1 ,3 ]
Thepot, Sylvain [3 ]
Esterni, Benjamin [2 ]
Quesnel, Bruno [3 ]
Rauzy, Odile Beyne [3 ]
Dreyfus, Francois [3 ]
Gardin, Claude [3 ]
Fenaux, Pierre [3 ]
Vey, Norbert [2 ,3 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Hematol Malignancies, Baltimore, MD 21218 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Grp Francophone Myelodysplasies, Bobigny, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 06期
关键词：
Myelodysplasia; acute myeloid leukaemia; azacitidine; relapse; outcome; CONVENTIONAL CARE REGIMENS;
D O I：
10.1111/j.1365-2141.2012.09076.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [21] Maintenance Azacitidine after Hematopoietic Stem Cell Transplantation for Relapse Prevention in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Americo, Andre Dias
    Kerbauy, Mariana Nassif
    da Silva, Cinthya Correa
    Chapchap, Eduardo Cerello
    Teixeira, Larissa
    de Souza dos Santos, Fabio Pirse
    Feitosa Ribeiro, Andreza Alice
    Hamerschlack, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S206 - S206
  • [22] Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
    Hashimoto, Miki
    Itonaga, Hidehiro
    Nannya, Yasuhito
    Taniguchi, Hirokazu
    Fukuda, Yuichi
    Furumoto, Takafumi
    Fujioka, Machiko
    Kasai, Sachie
    Taguchi, Masataka
    Taniguchi, Hiroaki
    Sato, Shinya
    Sawayama, Yasushi
    Atogami, Sunao
    Iwasaki, Keisuke
    Hata, Tomoko
    Soda, Hiroshi
    Moriuchi, Yukiyoshi
    Nakata, Koh
    Ogawa, Seishi
    Miyazaki, Yasushi
    INTERNAL MEDICINE, 2020, 59 (08) : 1081 - 1086
  • [23] Azacitidine in the "real-world': an evaluation of 1101 higher-risk myelodysplastic syndrome/low blast count acute myeloid leukaemia patients in Ontario, Canada
    Mozessohn, Lee
    Cheung, Matthew C.
    Fallahpour, Saber
    Gill, Tripat
    Maloul, Asmaa
    Zhang, Liying
    Lau, Olivia
    Buckstein, Rena
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (06) : 803 - 815
  • [24] Reduction of Extramedullary Complications in Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome Treated With Azacitidine
    Shabanova, Iren
    Cada, Michaela
    Johnston, Donna L.
    Abbott, Lesleigh S.
    Leung, Elaine W.
    Schechter, Tal
    Dror, Yigal
    Klaassen, Robert J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (03) : 170 - 174
  • [25] Azacitidine for the treatment of patients with acute myeloid leukemia
    Maurillo, Luca
    Venditti, Adriano
    Spagnoli, Alessandra
    Gaidano, Gianluca
    Ferrero, Dario
    Oliva, Esther
    Lunghi, Monia
    D'Arco, Alfonso M.
    Levis, Alessandro
    Pastore, Domenico
    Di Renzo, Nicola
    Santagostino, Alberto
    Pavone, Vincenzo
    Buccisano, Francesco
    Musto, Pellegrino
    CANCER, 2012, 118 (04) : 1014 - 1022
  • [26] Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients
    Peterlin, Pierre
    Cluzeau, Thomas
    Jullien, Maxime
    Ngo Nloga, Anne-Marie
    Calleja, Anne
    Angeli, Eurydice
    Chevallier, Patrice
    Guillaume, Thierry
    Garnier, Alice
    Le Bourgeois, Amandine
    Le Gouill, Steven
    Fenaux, Pierre
    Ades, Lionel
    Bally, Cecile
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) : 461 - 464
  • [27] Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)
    Wehmeyer, Juergen
    Zaiss, Matthias
    Losem, Christoph
    Schmitz, Stephan
    Niemeier, Beate
    Harde, Johanna
    Hannig, Carla Verena
    Harich, Hanns-Detlev
    Muller, Judith
    Klausmann, Martine
    Tessen, Hans Werner
    Potthoff, Karin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (06) : 766 - 773
  • [28] Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia
    Kenealy, Melita
    Hertzberg, Mark
    Benson, Warwick
    Taylor, Kerry
    Cunningham, Ilona
    Stevenson, Will
    Hiwase, Devendra
    Eek, Richard
    Zantomio, Daniela
    Jong, Steve
    Wall, Meaghan
    Blombery, Piers
    Gerber, Tracey
    Debrincat, Marlyse
    Zannino, Diana
    Seymour, John F.
    HAEMATOLOGICA, 2019, 104 (04) : 700 - 709
  • [29] Treatment of Relapsed Acute Myeloid Leukaemia
    Kell, Jonathan
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (02) : 103 - 111
  • [30] Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
    Ritchie, Ellen K.
    CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 165 - 173
12345